5 Most Profitable Pharmaceutical Stocks Now

2. Johnson & Johnson (NYSE:JNJ)

Trailing Twelve Month Net Income: $17.9 billion

Number of Hedge Fund Holders in Q3 2022: 85

Johnson & Johnson (NYSE:JNJ) is a healthcare and pharmaceutical company that makes and sells drugs and other products such as supplements. The firm is based in New Brunswick, New Jersey.

Johnson & Johnson (NYSE:JNJ) scored a big win in February 2023 when Alcon announced that it will pay the firm $199 million to settle legal disputes surrounding laser eye treatments. Insider Monkey’s third quarter of 2022 survey covering 920 hedge funds revealed that 85 had bought the company’s shares.

Johnson & Johnson (NYSE:JNJ)’s largest investor is Ken Fisher’s Fisher Asset Management which owns six million shares that are worth $1 billion.

Follow Johnson & Johnson (NYSE:JNJ)